trial · primary record
CLL-1-CD70 CAR-T Cell Injection
Acute Myeloid Leukemia (AML)
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 12 |
| Primary completion | 2029-11-30 |
| Primary endpoint | Safety: Number of Participants With Treatment-Emergent Adverse Events (TEAEs) |
| Registry ID | NCT07897136 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:37.322Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07897136
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.